These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17613643)

  • 1. A tolerance interval approach for assessment of agreement with left censored data.
    Choudhary PK
    J Biopharm Stat; 2007; 17(4):583-94. PubMed ID: 17613643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible Bayesian quantile regression for independent and clustered data.
    Reich BJ; Bondell HD; Wang HJ
    Biostatistics; 2010 Apr; 11(2):337-52. PubMed ID: 19948746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach for sample size determination in method comparison studies.
    Yin K; Choudhary PK; Varghese D; Goodman SR
    Stat Med; 2008 Jun; 27(13):2273-89. PubMed ID: 17979182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth estimation of survival functions and hazard ratios from interval-censored data using Bayesian penalized B-splines.
    Çetinyürek Yavuz A; Lambert P
    Stat Med; 2011 Jan; 30(1):75-90. PubMed ID: 20963752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression models for method comparison data.
    Dunn G
    J Biopharm Stat; 2007; 17(4):739-56. PubMed ID: 17613651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay validation for left-censored data.
    Barnhart HX; Song J; Lyles RH
    Stat Med; 2005 Nov; 24(21):3347-60. PubMed ID: 15977288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling HIV-RNA viral load in vertically infected children.
    Gray L; Cortina-Borja M; Newell ML
    Stat Med; 2004 Mar; 23(5):769-81. PubMed ID: 14981674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skew-normal Bayesian nonlinear mixed-effects models with application to AIDS studies.
    Huang Y; Dagne G
    Stat Med; 2010 Oct; 29(23):2384-98. PubMed ID: 20603815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian analysis of crossclassified spatial data with autocorrelation.
    Sun L; Clayton MK
    Biometrics; 2008 Mar; 64(1):74-84. PubMed ID: 17680834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity studies for quantitative assays: use of censored data analysis.
    Weusten JJ; Wouters PA; van Zuijlen MC
    Stat Med; 2003 Dec; 22(23):3629-40. PubMed ID: 14652865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hierarchical bayesian model for spatial prediction of multivariate non-gaussian random fields.
    Chagneau P; Mortier F; Picard N; Bacro JN
    Biometrics; 2011 Mar; 67(1):97-105. PubMed ID: 20374239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian approach to a logistic regression model with incomplete information.
    Choi T; Schervish MJ; Schmitt KA; Small MJ
    Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bayesian approach to the multistate Jolly-Seber capture-recapture model.
    Dupuis JA; Schwarz CJ
    Biometrics; 2007 Dec; 63(4):1015-22. PubMed ID: 17501941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian inference on age-specific survival for censored and truncated data.
    Colchero F; Clark JS
    J Anim Ecol; 2012 Jan; 81(1):139-49. PubMed ID: 21883202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric inference for surrogate endpoints with bivariate censored data.
    Ghosh D
    Biometrics; 2008 Mar; 64(1):149-56. PubMed ID: 17651457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Bayesian design for patient selection in a clinical study.
    Buzoianu M; Kadane JB
    Biometrics; 2009 Sep; 65(3):953-61. PubMed ID: 19021600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern-mixture models for multivariate incomplete data with covariates.
    Little RJ; Wang Y
    Biometrics; 1996 Mar; 52(1):98-111. PubMed ID: 8934587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation in Bayesian disease mapping.
    MacNab YC; Farrell PJ; Gustafson P; Wen S
    Biometrics; 2004 Dec; 60(4):865-73. PubMed ID: 15606406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.